Search results
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 2 days agoModerna Stock: Technical...The RS Rating is a 1-99 measure of a stock's 12-month performance. This...
On doorstep of approval, Merck compares V116 pneumococcal vaccine to 1983 warhorse Pneumovax 23
FierceBiotech· 5 days agoFive months ago, Merck revealed data that indicate its next-generation pneumococcal vaccine offers more protection for older adults than Pfizer’s market dominator Prevnar ...
FDA Says Vaccination Is the Best Protection Against Measles
Sierra Sun Times· 5 days agoMeasles is one of the most contagious respiratory diseases in the world that has the potential to be life-threatening. Vaccines approved by the U.S. Food and Drug Administration ...
Pfizer Lifts Profit Forecast as CEO Sees Reason for Optimism in 2024
US News & World Report· 3 days agoSales of Padcev, a treatment for advanced bladder cancer Pfizer gained through its $43 billion deal for Seagen, also came in ahead of analysts' expectations. The Seagen deal, as well as its ...
Realising the potential of correlates of protection for vaccine development, licensure and use:...
Nature· 5 days agoVaccines have had a significant impact on global morbidity and mortality over the last century, with estimates indicating that millions of lives are saved each year as a result ...
Who will RFK Jr. hurt more in 2024: Trump or Biden?
Yahoo News 360· 2 days ago12%); that vaccines cause autism (25% vs. 5%); and that chemicals in the water supply could turn children transgender (8% vs. 4%). For now, the Yahoo...
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks via Yahoo Finance· 3 days agoSI&A spending is expected in the range of $13...billion to $14.8 billion. The adjusted tax rate is...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 1 day agoGyre is also considering treatments for chronic obstructive pulmonary disease, or COPD, pulmonary...
Biotech Stocks Facing FDA Decision In May 2024
RTT News· 4 days agoAs April comes to an end, attention shifts to biotech stocks poised for regulatory events in May. The FDA approved eight novel drugs last May, contributing to a total of 55 approvals ...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 3 days agoThe RS Rating measures a stock's 12-month running performance against all other stocks. That RS...